Mid-tier Japanese Pharma companies determined end-stage & DOA @ ASCO -- and generally worldwide !

---

Mid-tier Japan Pharma companies determined DOA [ Dead on Arrival ] @ ASCO [ American Society of Clinical Oncology ] -- and worldwide

Outside of the Top-5 Pharma Companies in Japan, the mid-tier is AOL [ Absent Without Leave ] on the global biotech / pharma partnering scene


Dateline:  24 June 2011 -- 2:15 AM


While at ASCO the 1st week of this month I talked with many of my friends with 30 years' experience in biotech / pharma partnering and the vote was unanimous -- Japan's mid-tier pharma companies (and below!) have essentially disappeared from the world partnering stage -- versus their high level of partnering activity in the 1980s and 1990s.

The Japanese Top-5 Pharma's continue to over-spend liberally to make up for imminent patent expirations and 15 - 20 years of overly-conservative R&D and licensing, while the mid-tier players have either highly reduced their rate of international deal-making, or do not announce their deals.

And the latter is just as bad for their international competitiveness.  The penchant / tendency of mid-tier Japanese pharma's to hide from Society continues -- 30 years after I first thought it was stupid.

Sadly, as a result, the mid-tier will continue to merge and merge and submerge into obscurity and a deeper pernicious partnering anonymity.

In sum, if your company's strategic plan depends on doing business in Japan in a timely manner, guess again -- and have a Plan "B" and "C".


Posted by:

David A. Palella
Founder
BIOSCIENCE VENTURES Inc.

San Diego, California
cell: 619-787-5767
email:  dpalella@gmail.com
http://www.linkedin.com/in/davidpalella

web site:  http://www.BSVpartners.com

blog:  http://biobizdev.blogspot.com


& Group Founder:

Japan Biotech / Biopharma Partnering Forum
http://www.linkedin.com/e/vgh/2857975/

Biotech / Pharma Business Development, Licensing & Dealmaking
http://www.linkedin.com/e/-ubgx8c-gp40f4dt-22/vgh/3964633/

Asia Business & Finance Roundup
http://www.linkedin.com/e/vgh/3132759/

Infectious Disease R&D and Business Network
http://www.linkedin.com/e/-ubgx8c-godydbie-43/vgh/3937807/

Biofuels & Sustainable Chemicals Networking Group
http://www.linkedin.com/e/vgh/3891375/

X-tech Roundup(SM) - San Diego
http://www.linkedin.com/e/vgh/2836926


& Co-founder:

Stem Cells & Regenerative Medicine
http://www.linkedin.com/e/vgh/3921448


--------